Ignite Creation Date:
2024-05-06 @ 1:54 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04150887
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-09
First Post:
2019-11-01
Brief Title:
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
Sponsor:
OncoVerity Inc
Organization:
OncoVerity Inc
Organization Data
Organization:
OncoVerity Inc
Class:
INDUSTRY
Study ID:
ELEV20235
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OncoVerity Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| argenx | INDUSTRY |
| Janssen Research Development LLC | INDUSTRY |